Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

PubWeight™: 6.59‹?› | Rank: Top 1%

🔗 View Article (PMID 32031570)

Published in JAMA on February 07, 2020

Authors

Dawei Wang1, Bo Hu1, Chang Hu1, Fangfang Zhu1, Xing Liu1, Jing Zhang1, Binbin Wang1, Hui Xiang1, Zhenshun Cheng2, Yong Xiong3, Yan Zhao4, Yirong Li5, Xinghuan Wang6, Zhiyong Peng1

Author Affiliations

1: Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
2: Department of Pulmonary Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
3: Department of Infectious Disease, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
4: Department of Emergency Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
5: Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
6: Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.

Associated clinical trials:

The Efficacy and Safety of Thalidomide in the Adjuvant Treatment of Moderate New Coronavirus (COVID-19) Pneumonia | NCT04273529

The Efficacy and Safety of Thalidomide Combined With Low-dose Hormones in the Treatment of Severe COVID-19 | NCT04273581

A New Screening Strategy for 2019 Novel Coronavirus Infection | NCT04281693

Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID19 Infection (NoCovid) | NCT04290858

Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19. (NOSARSCOVID) | NCT04290871

Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) | NCT04320056

Hemodynamic Characteristics of Patients With SARS-CoV-2 (PiCCOVID) | NCT04337983

Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial (AZIQUINE-ICU) | NCT04339816

Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation (UPSAT) | NCT04344561

Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia (CCAP) | NCT04345289

Adipose Mesenchymal Cells for Abatement of SARS-CoV-2 Respiratory Compromise in COVID-19 Disease | NCT04352803

PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine | NCT04353037

Sevoflurane in COVID-19 ARDS (SevCov) | NCT04355962

Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) | NCT04358029

Passive Immunity Trial of Nashville II for COVID-19 (PassItOnII) | NCT04362176

Tocilizumab Treatment in Patients With COVID-19 | NCT04363853

Observational Cohort of COVID-19 Patients at Raymond-Poincare (COVID-RPC) | NCT04364698

The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families | NCT04365348

Repurposing of Chlorpromazine in Covid-19 Treatment (reCoVery) | NCT04366739

European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO (EuroECMO-COVID) | NCT04366921

Predicting Death and ICU Admission in COVID-19 Patients in ED | NCT04371562

Trial of Early Therapies During Non-hospitalized Outpatient Window for COVID-19 (TREATNOW) | NCT04372628

Efficacy of Convalescent Plasma Therapy in the Early Care of COVID-19 Patients. (PLASCOSSA) | NCT04372979

InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort (ILIAD-7-UK) | NCT04379076

Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 (CLUSCO) | NCT04379544

Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 | NCT04380870

The Global PCHF-COVICAV Registry (PCHF-COVICAV) | NCT04390555

Trial of Imatinib for Hospitalized Adults With COVID-19 | NCT04394416

Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury (TAC-COVID19) | NCT04395482

Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19 | NCT04397939

Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh | NCT04402203

COVID-19: Respiratory and Sleep Follow-up (Co-SURVIVORS) | NCT04406324

Protein Electrophoresis as a Tool for Complications Prediction in COVID-19 Hospitalised Patients (COVELEC) | NCT04414059

Primary Prevention of Infection by COVID-19 in Health Providers (PI-Covid-19) | NCT04420260

Prevalence and Characteristics of Pulmonary Embolism on COVID-19 Patients Presenting Respiratory Symptoms (COVID-EP) | NCT04420312

Use of Remote Monitoring for COVID-19 Patient (RPM) | NCT04425720

Predictive Factors COVID-19 Patients (MI-COVID) | NCT04427345

Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2 (ASTANA) | NCT04434261

Identification of Predictors for the Evolution of COVID-19 Related Pneumonia by Transcriptomic and Seroproteomic (COVID_OMICS) | NCT04441502

Effect of COVID-19 on Platelet Aggregation | NCT04447131

Determinants of SARS-COV2 (COVID-19) Persistence After Convalescence | NCT04448145

Arrhythmic Manifestations and Management in Hospitalized COVID-19 Patients | NCT04465552

Functional Exhaustion of T Cells in COVID19 Patients | NCT04470323

Hematology and Clinical Picture in Pediatric COVID-19 Infection | NCT04487119

Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive Patients (ETHIC) | NCT04492254

Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection | NCT04513158

Fenofibrate Intervention as COVID-19 Therapy (FERMIN) | NCT04517396

Coronavirus Induced Acute Kidney Injury: Prevention Using Urine Alkalinization | NCT04530448